Propanc Biopharma Publishes New Data on PRP and Resistant Pancreatic Cancer Cells
Propanc Biopharma says new data show PRP reprograms chemotherapy-resistant pancreatic cancer cells and restores therapeutic vulnerability.
Propanc Biopharma says new data show PRP reprograms chemotherapy-resistant pancreatic cancer cells and restores therapeutic vulnerability.